Dexak SL, 25 mg, granules for oral solution, 20 sachets

Dexak SL 25 mg 20 sachets

OTC medication

NAME OF MEDICINAL PRODUCT: Dexak SL, 25 mg, granules for oral solution.

QUANTITATIVEAND QUANTITATIVE COMPOSITION: each sachet of granules for oral solution contains: dexketoprofen (dexketoprofenum) 25 mg in the form of salt of dexketoprofen with tromethamol. Excipients: sucrose 2.418 g;

PHARMACEUTICAL FORM: granules for the preparation of oral solution, yellowish lemon in color.

INDICATIONSFOR USE Dexak SL

Short-term symptomatic treatment of acute pain of mild to moderate intensity, such as acute muscular and osteoarticular pain, painful menstruation and toothache.

INDICATIONS Dexak SL

Do not use in the following cases: hypersensitivity to the active substance, other drugs of the group of non-steroidal anti-inflammatory drugs (NSAIDs) or to any of the excipients; in patients in whom substances with a similar mechanism of action (eg. acetylsalicylic acid or other NSAIDs) cause asthma attacks, bronchospasm, acute rhinitis or cause nasal polyps, urticaria or angioedema; if there is a history of photoallergy or phototoxic reactions during treatment with ketoprofen or fibrates; in patients with a history of gastrointestinal bleeding or perforation associated with prior NSAID treatment; in patients with active peptic ulcer disease and/or gastrointestinal hemorrhage or any history of gastrointestinal bleeding, ulceration or perforation; in patients with chronic dyspepsia; in patients with other active bleeding or bleeding disorders; in patients with Crohn's disease or ulcerative colitis; in patients with severe heart failure; in patients with moderate or severe renal insufficiency (creatinine clearance ≤ 59 ml/min); in patients with severe hepatic impairment (10-15 on the Child-Pugh scale); in patients with hemorrhagic diathesis and other blood clotting disorders; in patients with severe dehydration (caused by vomiting, diarrhea or inadequate fluid supply); in women in the third trimester of pregnancy and during lactation.

RESPONSIBLE COMPANY WITH THE AUTHORIZATION TO MARKET Berlin-Chemie AG Glienicker Weg 125, 12489 Berlin Germany, updated 03.2023.

SCIENTIFICINFORMATION: BERLIN-CHEMIE/MENARINI POLSKA Sp. z o.o. , 4 Słomińskiego St., 00-204 Warsaw, tel. 22 566 21 00

Before use, read the leaflet, which contains indications, contraindications, data on adverse reactions and dosage, as well as information on the use of the medicinal product, or consult your doctor or pharmacist, as any drug used inappropriately threatens your life or health.